EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Incidence of Recurrent Invasive Pneumococcal Disease in Canada

Leah J Ricketson, Altynay Shigayeva, Irina Rajakumar, Zoe Zhong, Kazi Hassan, Irene Martin, Alyssa Golden, Allison J McGeer, James D Kellner, Calgary Area Epidemiology Research Group and the Toronto Invasive Bacterial Diseases Network

JAMA Network Open · 07.07.2026 · 9 (7) · e2621797

DOI: 10.1001/jamanetworkopen.2026.21797 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA Network Open, online erschienen am 07.07.2026. Verfasst von Leah J Ricketson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Pneumococcal Infections. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Recurrent invasive pneumococcal disease (rIPD) constitutes a clinically relevant proportion of all IPD cases. Improved understanding of these cases can inform priorities for prevention through vaccination.

Objective

To describe the incidence of rIPD and associated risk factors in adults with a primary episode of IPD. Design, Setting, and Participants This population-based, multicenter cohort study was performed during active surveillance for IPD in adults in Calgary and the Toronto-Peel regions of Canada from January 1, 2004, to December 31, 2022. rIPD was defined as IPD occurring 30 days or longer after a primary episode. Canadian reference laboratories performed serotyping; population data were obtained from Statistics Canada and the Alberta Interactive Health Data Application. Data were analyzed from September 3, 2024, to November 28, 2025. Main Outcomes and Measures Incidence of rIPD over time. Risk factors for rIPD were assessed using multivariable logistic regression.

Results

From 2004 to 2022, 7006 adult patients survived a primary episode of IPD, 274 (3.9%) of whom had rIPD. The median age at primary infection in patients with rIPD was 53.6 (IQR, 41.4-66.0) years; 168 patients (61.3%) were male. The incidence rate ratio (IRR) of rIPD compared with primary IPD rate in surveillance populations was highest in the first year after primary IPD (IRR, 152; 95% CI, 124-185). From 5 to 17 years after primary IPD, the IRR was 15 (95% CI, 11-20). Factors associated with recurrent disease included history of stem cell transplant or hematologic cancer (odds ratio [OR], 5.17; 95% CI, 3.35-7.98), HIV infection (OR, 4.47; 95% CI, 2.84-7.04), experiencing homelessness (OR, 1.87; 95% CI, 1.30-2.69), and alcohol use disorder (OR, 1.50; 95% CI, 1.07-2.11). Primary infection with serotype 3 (OR, 0.33; 95%, 0.16-0.67) or serotype 7F (OR, 0.42; 95% CI, 0.21-0.87), and being 65 years or older (OR, 0.55; 95% CI, 0.34-0.90) were associated with reduced odds of rIPD. At the primary episode, 4812 of 5470 patients (88.0%) were eligible for pneumococcal vaccine, and 1344 of 4812 (27.9%) had been vaccinated. Of patients with known vaccine status between the first and second episodes, 167 of 229 (72.9%) were eligible for vaccine and only 37 of 167 (22.2%) received one. Conclusions and Relevance In this cohort study, the risk of rIPD was higher than the risk of primary IPD throughout 17 years of follow-up. Most patients with primary IPD had indications for pneumococcal vaccine but were unvaccinated. These findings suggest that patients with IPD should be prioritized to receive recommended vaccination doses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumococcal InfectionsHumansIncidenceFemaleMaleCanadaRisk FactorsRecurrenceMiddle AgedAdultAgedStreptococcus pneumoniaeCohort Studies

Autor:innen und Institutionen

  • Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
  • Toronto Invasive Bacterial Disease Network, Sinai Health System, Toronto, Ontario, Canada.
  • Alberta Health Services, Calgary, Alberta, Canada.
  • National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Zitieren

APA

Ricketson, L. J., Shigayeva, A., Rajakumar, I., Zhong, Z., Hassan, K., Martin, I., Golden, A., McGeer, A. J., Kellner, J. D., & Calgary Area Epidemiology Research Group and the Toronto Invasive Bacterial Diseases Network (2026). Incidence of Recurrent Invasive Pneumococcal Disease in Canada. JAMA Network Open, 9(7), e2621797. https://doi.org/10.1001/jamanetworkopen.2026.21797

Vancouver

Ricketson LJ, Shigayeva A, Rajakumar I, Zhong Z, Hassan K, Martin I, et al. Incidence of Recurrent Invasive Pneumococcal Disease in Canada. JAMA Network Open. 2026;9(7):e2621797. doi:10.1001/jamanetworkopen.2026.21797

BibTeX
@article{Ricketson2026,
  author = {Ricketson, Leah J and Shigayeva, Altynay and Rajakumar, Irina and Zhong, Zoe and Hassan, Kazi and Martin, Irene and Golden, Alyssa and McGeer, Allison J and Kellner, James D and Calgary Area Epidemiology Research Group and the Toronto Invasive Bacterial Diseases Network, Calgary Area Epidemiology Research Group and the Toronto Invasive Bacterial Diseases Network},
  title = {Incidence of Recurrent Invasive Pneumococcal Disease in Canada},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {7},
  pages = {e2621797},
  doi = {10.1001/jamanetworkopen.2026.21797}
}
Kostenlos starten →